Log In
BCIQ
Print this Print this
 

Onko-Sure (formerly next generation DR-70)

  Manage Alerts
Collapse Summary General Information
Company Radient Pharmaceuticals Corp.
DescriptionNon-invasive, in vitro immunoassay kit that detects the level of fibrin-fibrinogen degradation product (FDP) in blood samples
Molecular Target Not applicable
Mechanism of ActionDiagnostic
Therapeutic ModalityDiagnostics
Latest Stage of DevelopmentMarketed
Standard IndicationCancer, Diagnostic
Indication DetailsDiagnose cancer; Diagnose colorectal cancer; Diagnose lung cancer
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

6

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today